Dergiler / European Journal of Therapeutics / 2022 / Cilt: 28 - Sayı: 1

The Prognostic Importance of Neutrophil-toLymphocyte Ratio and Platelet-toLymphocyte Ratio in Adult Patients with Sepsis Who Underwent Hemoperfusion in General Intensive Care Unit

Sayfa
37–44
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: It is thought that it may be a cheap and useful biomarker in the prognosis of patients who are followed up in the intensive care unit and are treated with HA-330 sepsis adsorption column since the rate of neutrophils and lymphocytes in patients with hematological healing and death differs greatly.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Sepsis is a major cause of mortality and morbidity in the intensive care units.
📊
Temel Bulgular & Veri:The goal of this study is to investigate whether changes in the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are a prognostic marker for patients with sepsis (according to sepsis stages, and patient’s and disease’s characteristics) who have been followed up in the intensive care unit and who have received HA330 resin-directed hemadsorption column for sepsis.
💡
Sonuç & Katkı:Conclusion: It is thought that it may be a cheap and useful biomarker in the prognosis of patients who are followed up in the intensive care unit and are treated with HA-330 sepsis adsorption column since the rate of neutrophils and lymphocytes in patients with hematological healing and death differs greatly.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Sepsis is a major cause of mortality and morbidity in the intensive care units. The goal of this study is to investigate whether changes in the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are a prognostic marker for patients with sepsis (according to sepsis stages, and patient’s and disease’s characteristics) who have been followed up in the intensive care unit and who have received HA330 resin-directed hemadsorption column for sepsis. Methods: The study included a group of 100 (male [healed: 19, exitus: 42], female [cured: 29, exitus: 10]) sepsis patients who were followed up in the intensive care unit between December 2019 and December 2021 and who received HA-330 sepsis adsorption column. Results: Although a strong positive correlation was found between the neutrophil-to-lymphocyte ratio and the baseline platelet-to-lymphocyte ratio values (r=0.725 and P = .001), a weak positive correlation was found between the baseline neutrophil-to-lymphocyte ratio and the comorbidity values (r = 0.253 and P=.001). In addition, the period found for hemoperfusion in those who healed was statistically significantly higher in exitus patients (P=.001). It was noted that the improvement in repeated neutrophil-to-lymphocyte ratio measurements in the healing and death observations was identical (P > .05). The repeated neutrophil-to-lymphocyte ratio measurement values were found to be statistically significantly different for those with healing (P=.014). In addition, repeated neutrophil-to-lymphocyte ratio measurement values were found to be statistically significantly different from those with exitus (P=.001). It was observed that the change of repeated platelet-to-lymphocyte ratio measurements in the observations with healing and death was statistically significant (P < .05). Conclusion: It is thought that it may be a cheap and useful biomarker in the prognosis of patients who are followed up in the intensive care unit and are treated with HA-330 sepsis adsorption column since the rate of neutrophils and lymphocytes in patients with hematological healing and death differs greatly.

🔖

Bu Makaleye Atıf Yap

ÖZER, T., KOÇ, S., KARADAĞ, M., KAPTANOĞULLARI, H., KÜÇÜKCERİT, T. Ş., KARAOĞUZ, B., CELEP, Y. E., AKTEPE, E., DİZMEN, H., TULUM, B., KUAS, E., İLERİ, A., DOKUR, S. N., DOKUR, M. (2022). The Prognostic Importance of Neutrophil-toLymphocyte Ratio and Platelet-toLymphocyte Ratio in Adult Patients with Sepsis Who Underwent Hemoperfusion in General Intensive Care Unit. European Journal of Therapeutics, Cilt: 28 - Sayı: 1, 37–44. https://ajindex.com/articles/512117

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801-810. [CrossRef] 2. Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):775-787. [CrossRef] 3. Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):762-774. [CrossRef] 4. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304-377. [CrossRef] 5. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644-1655. [CrossRef] 6. Levy MM, Fink MP, Marshall JC, et al. 2001 sccm/esicm/accp/ats/sis international sepsis definitions conference. Intensive Care Med. 2003;29(4):530-538. [CrossRef] 7. Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority - a WHO resolution. N Engl J Med. 2017;377(5):414-417. [CrossRef] 8. Liu V, Escobar GJ, Greene JD, et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014;312(1):90-92. [CrossRef] 9. Burrell AR, McLaws ML, Fullick M, Sullivan RB, Sindhusake D. SEPSIS KILLS: early intervention saves lives. Med J Aust. 2016;204(2):73. [CrossRef] 10. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486-552. [CrossRef] 11. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589- 1596. [CrossRef] 12. Seymour CW, Gesten F, Prescott HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235-2244. [CrossRef] 13. Shum HP, Yan WW, Chan TM. Extracorporeal blood purification for sepsis. Hong Kong Med J. 2016;22(5):478-485. [Cros